Sacrocolpopexy is a surgical procedure that lifts the top of the vagina back into its normal position by anchoring it to the tailbone with a piece of surgical mesh. It’s considered the most durable surgical option for pelvic organ prolapse, with short-term anatomic success rates above 98% and long-term success holding around 73% to 78% at seven years.
How the Procedure Works
During sacrocolpopexy, a surgeon first separates the bladder and rectum from the vaginal walls to create space for the mesh. A piece of polypropylene mesh is then sutured to both the front and back walls of the upper vagina (or the vaginal stump, if you’ve had a hysterectomy). The other end of the mesh is attached to a ligament covering the sacrum, the triangular bone at the base of your spine. Because the sacrum sits higher than the vagina, the mesh acts like a bridge or synthetic ligament, pulling the vaginal vault upward and holding it in place.
If your uterus is still in place, a variation called sacrouteropexy uses the same approach to support the cervix and uterus rather than the vaginal vault alone.
Who Needs This Surgery
Sacrocolpopexy is typically recommended for women with advanced pelvic organ prolapse, particularly stages III and IV on the clinical grading scale. At these stages, the vaginal vault or uterus has dropped significantly, often bulging at or beyond the vaginal opening. Common symptoms include a feeling of heaviness or pressure in the pelvis, difficulty with bladder or bowel function, and discomfort during intercourse. The procedure is most commonly performed after a hysterectomy, though it can also be done with the uterus in place.
Open, Laparoscopic, and Robotic Approaches
The surgery can be performed three different ways, and the approach your surgeon recommends will affect your hospital stay, pain levels, and recovery time.
Open (abdominal) sacrocolpopexy involves a larger incision in the abdomen. It has a long track record with over 90% success rates, but it comes with more blood loss, more postoperative pain, and a longer hospital stay compared to the minimally invasive options.
Laparoscopic sacrocolpopexy uses small incisions and a camera to guide the surgery. It reduces blood loss and pain significantly compared to the open approach and shortens hospital stays. Operating times average roughly 200 to 225 minutes. The trade-off is a steep learning curve for surgeons, since the instruments have limited range of motion and the view is two-dimensional.
Robotic-assisted sacrocolpopexy addresses many of those limitations. The robotic system gives the surgeon a three-dimensional view, eliminates hand tremor, and uses wristed instruments that move more naturally inside the body. Operating times run slightly longer, around 245 to 265 minutes in some studies, though other trials have found no meaningful difference between robotic and laparoscopic times. Surgeons also report less neck, shoulder, and back strain with the robotic system.
For minimally invasive approaches, average hospital stays run about 2.5 to 3 days.
How It Compares to Native Tissue Repair
The main alternative to sacrocolpopexy is a vaginal procedure called uterosacral ligament suspension, which uses your own tissue and permanent sutures rather than mesh. At one year, both procedures provide similar support at the top of the vagina, with 97% success rates for the apex in both groups.
Where they diverge is the front vaginal wall. Sacrocolpopexy had a 97.9% success rate in the anterior compartment compared to 94.9% for the vaginal approach. The mesh-based repair also maintained greater vaginal length. Blood loss was substantially lower with sacrocolpopexy (about 78 mL versus 187 mL), and fewer patients had trouble emptying their bladder afterward: 8% compared to 20%.
The vaginal approach does have some advantages. It avoids mesh entirely, which eliminates mesh-specific complications. But permanent suture exposure was significantly more common after vaginal repair, occurring in 6.1% of patients compared to less than 1% after sacrocolpopexy.
Mesh Complications
The mesh used in sacrocolpopexy is placed internally, attached to the vaginal walls and sacrum deep inside the pelvis. This is distinct from transvaginal mesh kits, which were the focus of major safety concerns and FDA action. Still, sacrocolpopexy mesh carries its own risk of erosion, where the mesh works its way through the vaginal lining and becomes exposed.
Reported erosion rates range from 2% to 10% across different studies. In one series of 188 minimally invasive procedures, 10% developed erosion. When erosion does occur, it sometimes requires a minor surgical procedure to trim or remove the exposed portion. The risk appears to increase when a hysterectomy is performed at the same time as the sacrocolpopexy, likely because the healing vaginal cuff is more vulnerable.
Recovery and Activity Restrictions
After a minimally invasive sacrocolpopexy, current protocols encourage resuming a normal lifestyle quickly. Patients are typically advised to eat a balanced diet, stay well hydrated, and begin regular physical activity starting the day after discharge.
That said, about 60% of gynecologic surgeons still recommend avoiding heavy lifting for at least six weeks after surgery. The most common weight limit is around 4.5 kg (roughly 10 pounds), equivalent to a gallon of milk. Recent research has questioned whether this restriction makes much practical sense. Simply standing up from a chair generates enough abdominal pressure to equal lifting about 6 kg, more than the limit most surgeons impose. Some newer studies have compared patients who resumed full activity, including running and heavy lifting, against those who followed traditional restrictions, and found no difference in outcomes. The trend in surgical recovery is moving toward earlier return to normal activity, in line with Enhanced Recovery After Surgery protocols.
Effects on Sexual Function
Prolapse itself frequently causes pain during sex, and sacrocolpopexy often improves this. In a study of 224 women, 39% reported that pain limited intercourse before surgery. One year later, that number dropped to 21%. Among women who specifically had pain before the procedure, 58% reported that the pain resolved after surgery.
New onset pain is possible but less common. About 14.5% of women who had no pain before surgery reported some discomfort during intercourse afterward. Women who had a posterior vaginal wall repair at the same time as the sacrocolpopexy were somewhat more likely to develop new pain, though the difference was not statistically significant. Overall, the majority of sexually active women experienced improvements in sexual function, including fewer pelvic floor symptoms that had been interfering with intimacy.
Long-Term Durability
Short-term results are excellent. A meta-analysis of robotic sacrocolpopexy studies found a combined anatomic success rate of 98.6% at an average follow-up of about 27 months. These results mirror the success rates historically seen with open abdominal sacrocolpopexy at similar timepoints.
Over longer periods, some recurrence is expected. Data from the extended CARE trial, which tracked patients for seven years after open sacrocolpopexy, found anatomic failure rates of 22% to 27%. “Failure” in these studies is defined by physical exam measurements and doesn’t always mean symptoms have returned. Many women with mild anatomic recurrence remain symptom-free and don’t need further treatment. When reoperation is needed, rates hover around 8% to 9% after mesh-based repair.